Because IFNα and pDCs have been implicated in autoantibody production in SLE pathogenesis [3], we measured the IFNα level in the blood of both ANA-positive and ANA-negative RA patients treated by infliximab. The gene discussed is BTG3; the disease is systemic lupus erythematosus.